Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
May take longer based on weather, holiday, or lab delays
Novo Nordisk's strategy involves defending its Indian market by combining its premium brand with local distribution strength and lowering prices
Legality and safety vary: a generic produced in India under that country's legal framework is not FDA-approved for import into the U.S., and purchasing it exposes patients to customs seizure risk and product quality uncertainty
Tirzepatide Research# SURPASS program (Type 2 diabetes): Five Phase 3 trials demonstrating superior HbA1c reduction compared to insulin glargine, semaglutide, and insulin degludec SURMOUNT program (Obesity): Phase 3 trials showing up to 20.9% weight loss at 72 weeks FDA approvals : Mounjaro (May 2022) for T2D
_edited.jpg)
US$ 22.89
US$ 28.86
US$ 28.15
US$ 24.11
US$ 24.72
US$ 26.04
